Kala Bio, Inc. (KALA)
2.23
-0.06
(-2.62%)
USD |
NASDAQ |
May 29, 16:00
2.23
0.00 (0.00%)
After-Hours: 20:00
Kala Bio Shareholders Equity (Quarterly) : 10.76M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Acurx Pharmaceuticals, Inc. | 7.013M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Anika Therapeutics, Inc. | 133.90M |
| Savara, Inc. | 176.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.32M |
| Total Liabilities (Quarterly) | 1.557M |
| Current Ratio | 7.911 |
| Net Debt Paydown Yield | 4.09% |